课题基金 / 基金详情

Development of an orally delivered genital herpes vaccine: targeting the reproductive tract using Liporale, a novel lipid-based adjuvant

Development of an orally delivered genital herpes vaccine: targeting the reproductive tract using Liporale, a novel lipid-based adjuvant
口服生殖器疱疹疫苗的开发:使用Liporale(一种新型脂质佐剂)靶向生殖道
批准号:
LP110200985
负责人:
Prof Kenneth Beagley
金额:
$9.02万
依托单位国家:
澳大利亚
项目类别:
Linkage Projects
财政年份:
2011
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2011-12-01 至 2014-12-31

项目摘要

项目成果

Prof Kenneth Beagley的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This project will evaluate the potential of a novel lipid-based adjuvant platform, LiporaleTM, to induce protection against a model sexually transmitted infection, genital herpes, using an orally delivered vaccination approach. Currently 16 per cent of the world's population has been exposed to herpes and there is currently no effective vaccine available.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Specificity of Chlamydia pneumoniae for humans : analysis of previous cross-host transmission events and the role of tryptophan availability in host specificity
  • 批准号:
    nhmrc : 1004666
  • 项目类别:
    Project Grants
  • 资助金额:
    $27.58万
  • 财政年份:
    2011
  • 负责人:
    Prof Kenneth Beagley
  • 依托单位:
Development of an effective vaccine for chlamydial infection: optimisation of a non-toxic cholera toxin-based adjuvant to generate a protective mucosal response
  • 批准号:
    LP0884020
  • 项目类别:
    Linkage Projects
  • 资助金额:
    $7.23万
  • 财政年份:
    2009
  • 负责人:
    Prof Kenneth Beagley
  • 依托单位:
Development of a vaccine for genital chlamydia infections: protection against transmission and disease pathology
  • 批准号:
    nhmrc : 553026
  • 项目类别:
    NHMRC Project Grants
  • 资助金额:
    $21.49万
  • 财政年份:
    2009
  • 负责人:
    Prof Kenneth Beagley
  • 依托单位:
Investigation of the association between chlamydial infection and asthma in different age groups
  • 批准号:
    nhmrc : 401238
  • 项目类别:
    NHMRC Project Grants
  • 资助金额:
    $25.48万
  • 财政年份:
    2008
  • 负责人:
    Prof Kenneth Beagley
  • 依托单位:
海外基金